Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,923,394
+$201,296 QoQ
Shares Held
16,271
+18.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $50,240,980 across 18 Drug Manufacturers - Specialty & Generic names. ZTS ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
185,629 | $14,274,870 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,337,693 | $12,734,837 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
56,615 | $7,458,460 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,290 | $2,543,884 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
48,765 | $2,520,662 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
43,599 | $2,099,291 | |
| 7 | ZTS |
Zoetis Inc.
This page
|
16,271 | $1,923,394 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
296,431 | $1,719,299 |
All Filings in ZTS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,923,394 | 16,271 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,722,098 | 13,687 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,565,086 | 24,365 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $865,366 | 5,549 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $738,619 | 4,486 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $308,100 | 1,891 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $531,868 | 3,068 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,197,271 | 60,264 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $700,722 | 4,069 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $8,899,688 | 60,728 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,020,493 | 47,343 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $599,896 | 3,490 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $16,350,753 | 86,700 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,986,160 | 8,139 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,361,518 | 12,164 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $1,253,540 | 7,960 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $1,151,471 | 6,963 | Shares | Sole | 2020-11-19 | |
| 2020-03-31 | $863,962 | 7,341 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||